This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Drugs

Quant Model High on Healthcare, Biotech Says Rx Fund Manager Wruble

Healthcare and biotech stocks are very strong from a quantitative perspective while utilities are having problems powering ahead said Steven Wruble, portfolio manager for the Rx Premier Managers Fund.

07/07/15 - 10:00 AM EDT

Blame Keryx Executives, Not Short Sellers, for Dismal Drug Launch, Sinking Stock

  • Tickers in this article:
  • KERX

Short sellers -- "manipulative" or otherwise -- are not responsible for Keryx's withering stock price. The problem is Auryxia, the company's kidney dialysis drug.

07/07/15 - 07:43 AM EDT

Try Jim Cramer's Action Alerts PLUS
Horizon Goes Hostile With $3 Billion Takeout Offer for Depomed

Horizon Goes Hostile With $3 Billion Takeout Offer for Depomed

Like other specialty pharmaceutical makers headquartered in tax-friendly countries, Horizon is buying growth.

07/07/15 - 07:29 AM EDT

NYSE Executive Expects Plethora of IPOs to Continue

NYSE Executive Expects Plethora of IPOs to Continue

Garvis Toler, head of global capital market for the exchange, said the JOBs Act has encouraged companies to go public, a trend he expects to continue.

07/06/15 - 04:55 PM EDT

Biotech, Health Care Likely to Drive IPOs at NYSE in Second Half

Biotech, Health Care Likely to Drive IPOs at NYSE in Second Half

Garvis Toler, head of global capital markets at the NYSE, reviews the landscape of IPOs during the first half of 2015 and previews what's in store for the second half.

07/06/15 - 02:52 PM EDT

Applied Genetic Technologies (AGTC) Stock Climbs on $124 Million Biogen Deal

Applied Genetic Technologies (AGTC) Stock Climbs on $124 Million Biogen Deal

  • Tickers in this article:
  • AGTC

Applied Genetic Technologies (AGTC) shares are rising after the company announced a $124 million development deal with Biogen (BIIB).

07/02/15 - 03:27 PM EDT

Will Medicines & Co. (MDCO) Stock be Hurt by Court Patent Ruling?

Will Medicines & Co. (MDCO) Stock be Hurt by Court Patent Ruling?

  • Tickers in this article:
  • MDCO

Medicines & Co. (MDCO) shares have been gaining all day before a court ruling on its patent infringement claims against Hospira (HSP).

07/02/15 - 02:16 PM EDT

Biotech Stock Mailbag: Grading 2015 Biotech Predictions at the Halfway Point

Biotech Stock Mailbag: Grading 2015 Biotech Predictions at the Halfway Point

Biotech columnist Adam Feuerstein answers readers' questions about health care.

07/02/15 - 12:54 PM EDT

Teladoc Shares Surge in NYSE Debut as Investors Focus on 'Telehealth'

Teladoc Shares Surge in NYSE Debut as Investors Focus on 'Telehealth'

  • Tickers in this article:
  • TDOC

Teladoc (TDOC) jumped 50 percent in its first day of trading as investors gobbled up shares of the first so-called telehealth company to go public.

07/01/15 - 05:32 PM EDT

PE-backed KIK Custom Products Gets Sold After Long Hold

PE-backed KIK Custom Products Gets Sold After Long Hold

  • Tickers in this article:
  • CHMT

Private equity firm Centerbridge Partners will acquire KIK, a maker of pool treatment and other products.

07/01/15 - 05:26 PM EDT

Gannett, Energizer in Focus Amid Huge Week For Corporate Spin-Offs

Gannett, Energizer in Focus Amid Huge Week For Corporate Spin-Offs

Beyond Greece, Puerto Rico and the June jobs report, Investors should also be aware of a big number of corporate spin-offs this week.

07/01/15 - 02:43 PM EDT

Cramer Worried About Airline Overcapacity, Hints at Surprise McDonald's Piece

Cramer Worried About Airline Overcapacity, Hints at Surprise McDonald's Piece

Jim Cramer likes Soutwest (LUV), isn't a fan of Sarepta Therapeutics (SRPT) and will soon have a 'surprise' piece on McDonald's (MCD).

07/01/15 - 02:40 PM EDT

Rock Creek (RCPI) Stock Spikes on Positive Proof of Principle Drug Study Results

Rock Creek (RCPI) Stock Spikes on Positive Proof of Principle Drug Study Results

  • Tickers in this article:
  • RCPI

Rock Creek Pharmaceuticals (RCPI) shares are up over 15% after the company reported positive results from its human proof of principal tests.

07/01/15 - 01:40 PM EDT

U.S. Stocks Open Higher, Possible Compromise in Greek Debt Talks

U.S. Stocks Open Higher, Possible Compromise in Greek Debt Talks

U.S. stocks opened higher on reports that Greek Prime Minister Alexis Tsipras sent a letter to European creditors agreeing to most conditions of a financing deal.

07/01/15 - 09:49 AM EDT

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Markets

DOW 17,776.91 +93.33 0.53%
S&P 500 2,081.34 +12.58 0.61%
NASDAQ 4,997.4590 +5.5190 0.11%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs